PDB Short entry for 2OM9 HEADER TRANSCRIPTION 21-JAN-07 2OM9 TITLE AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 232-505; COMPND 5 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PPAR GAMMA, AJULEMIC ACID, CANNABINOID, PARTIAL AGONIST, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.L.B.AMBROSIO,R.C.GARRATT REVDAT 5 30-AUG-23 2OM9 1 REMARK REVDAT 4 13-JUN-18 2OM9 1 COMPND SOURCE REMARK SEQADV REVDAT 3 24-FEB-09 2OM9 1 VERSN REVDAT 2 24-JUL-07 2OM9 1 JRNL REVDAT 1 24-APR-07 2OM9 0 JRNL AUTH A.L.B.AMBROSIO,S.M.G.DIAS,I.POLIKARPOV,R.B.ZURIER, JRNL AUTH 2 S.H.BURSTEIN,R.C.GARRATT JRNL TITL AJULEMIC ACID, A SYNTHETIC NONPSYCHOACTIVE CANNABINOID ACID, JRNL TITL 2 BOUND TO THE LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME JRNL TITL 3 PROLIFERATOR-ACTIVATED RECEPTOR GAMMA JRNL REF J.BIOL.CHEM. V. 282 18625 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17462987 JRNL DOI 10.1074/JBC.M702538200 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 39850 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2128 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2732 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.35 REMARK 3 BIN R VALUE (WORKING SET) : 0.3430 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.4310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8508 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 232 REMARK 3 SOLVENT ATOMS : 213 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -2.21000 REMARK 3 B33 (A**2) : 2.46000 REMARK 3 B12 (A**2) : -1.29000 REMARK 3 B13 (A**2) : 0.43000 REMARK 3 B23 (A**2) : 0.02000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.951 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.368 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.250 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.149 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.877 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8912 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12052 ; 1.586 ; 2.023 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1056 ; 5.511 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 382 ;40.276 ;25.393 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1698 ;18.942 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;17.747 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1390 ; 0.175 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6436 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4420 ; 0.224 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6271 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 376 ; 0.136 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 48 ; 0.251 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.158 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5300 ; 0.534 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8592 ; 1.007 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3612 ; 1.223 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3458 ; 2.046 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 207 A 476 3 REMARK 3 1 C 207 C 476 3 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1081 ; 0.02 ; 0.05 REMARK 3 LOOSE POSITIONAL 1 A (A): 1090 ; 0.07 ; 5.00 REMARK 3 TIGHT THERMAL 1 A (A**2): 1081 ; 0.06 ; 0.50 REMARK 3 LOOSE THERMAL 1 A (A**2): 1090 ; 0.07 ; 10.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : B D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 207 B 476 2 REMARK 3 1 D 207 D 476 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 B (A): 1040 ; 0.02 ; 0.05 REMARK 3 MEDIUM POSITIONAL 2 B (A): 1050 ; 0.07 ; 0.50 REMARK 3 TIGHT THERMAL 2 B (A**2): 1040 ; 0.06 ; 0.50 REMARK 3 MEDIUM THERMAL 2 B (A**2): 1050 ; 0.08 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 207 A 476 REMARK 3 ORIGIN FOR THE GROUP (A): 13.9547 -20.0960 -36.9785 REMARK 3 T TENSOR REMARK 3 T11: -0.0430 T22: -0.0659 REMARK 3 T33: -0.0118 T12: -0.0145 REMARK 3 T13: -0.0304 T23: 0.0298 REMARK 3 L TENSOR REMARK 3 L11: 0.9230 L22: 0.7037 REMARK 3 L33: 1.0911 L12: 0.2970 REMARK 3 L13: -0.5203 L23: 0.1254 REMARK 3 S TENSOR REMARK 3 S11: 0.0023 S12: -0.0182 S13: -0.0179 REMARK 3 S21: 0.0833 S22: 0.0013 S23: -0.1079 REMARK 3 S31: -0.0252 S32: -0.0787 S33: -0.0036 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 207 B 476 REMARK 3 ORIGIN FOR THE GROUP (A): -2.2829 6.9930 -23.5398 REMARK 3 T TENSOR REMARK 3 T11: -0.0267 T22: -0.0071 REMARK 3 T33: -0.1018 T12: -0.0292 REMARK 3 T13: -0.0342 T23: -0.0550 REMARK 3 L TENSOR REMARK 3 L11: 1.2770 L22: 1.5697 REMARK 3 L33: 1.1914 L12: 0.0500 REMARK 3 L13: -0.4171 L23: -0.6638 REMARK 3 S TENSOR REMARK 3 S11: -0.0830 S12: -0.1382 S13: 0.1370 REMARK 3 S21: 0.1228 S22: 0.0489 S23: -0.0830 REMARK 3 S31: 0.1015 S32: -0.1897 S33: 0.0341 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 207 C 476 REMARK 3 ORIGIN FOR THE GROUP (A): -17.1395 -38.6444 -61.8458 REMARK 3 T TENSOR REMARK 3 T11: -0.0307 T22: -0.0701 REMARK 3 T33: -0.0195 T12: 0.0087 REMARK 3 T13: 0.0281 T23: 0.0168 REMARK 3 L TENSOR REMARK 3 L11: 1.0792 L22: 0.7033 REMARK 3 L33: 0.8380 L12: -0.2394 REMARK 3 L13: 0.4303 L23: 0.2074 REMARK 3 S TENSOR REMARK 3 S11: 0.0019 S12: -0.0009 S13: -0.0059 REMARK 3 S21: -0.0637 S22: -0.0021 S23: -0.1006 REMARK 3 S31: 0.0005 S32: -0.0597 S33: 0.0002 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 207 D 476 REMARK 3 ORIGIN FOR THE GROUP (A): 29.0343 12.4034 -75.2550 REMARK 3 T TENSOR REMARK 3 T11: -0.0237 T22: -0.0295 REMARK 3 T33: -0.1038 T12: 0.0130 REMARK 3 T13: 0.0507 T23: -0.0482 REMARK 3 L TENSOR REMARK 3 L11: 1.3385 L22: 1.5629 REMARK 3 L33: 1.1319 L12: -0.0604 REMARK 3 L13: 0.4680 L23: -0.5549 REMARK 3 S TENSOR REMARK 3 S11: -0.0934 S12: 0.1015 S13: -0.0709 REMARK 3 S21: -0.1426 S22: 0.0547 S23: -0.1101 REMARK 3 S31: -0.0938 S32: -0.1453 S33: 0.0387 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2OM9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041311. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JAN-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42977 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : 0.09000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : 0.35000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4M SODIUM FORMATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 200 REMARK 465 SER A 201 REMARK 465 HIS A 202 REMARK 465 MET A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 TYR A 477 REMARK 465 GLY B 200 REMARK 465 SER B 201 REMARK 465 HIS B 202 REMARK 465 MET B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 TYR B 477 REMARK 465 GLY C 200 REMARK 465 SER C 201 REMARK 465 HIS C 202 REMARK 465 MET C 203 REMARK 465 LEU C 204 REMARK 465 ASN C 205 REMARK 465 PRO C 206 REMARK 465 TYR C 477 REMARK 465 GLY D 200 REMARK 465 SER D 201 REMARK 465 HIS D 202 REMARK 465 MET D 203 REMARK 465 LEU D 204 REMARK 465 ASN D 205 REMARK 465 PRO D 206 REMARK 465 GLY D 239 REMARK 465 LYS D 240 REMARK 465 THR D 241 REMARK 465 THR D 242 REMARK 465 ASP D 243 REMARK 465 LEU D 270 REMARK 465 GLN D 271 REMARK 465 GLU D 272 REMARK 465 GLN D 273 REMARK 465 SER D 274 REMARK 465 TYR D 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 240 45.92 -78.94 REMARK 500 ASP A 243 140.39 -30.66 REMARK 500 SER A 342 73.38 53.11 REMARK 500 LEU A 393 44.64 -77.81 REMARK 500 GLU A 427 40.62 -99.44 REMARK 500 SER A 428 92.13 -166.01 REMARK 500 ASP A 462 63.78 -108.46 REMARK 500 SER A 464 19.42 -142.69 REMARK 500 LEU A 465 115.44 -15.62 REMARK 500 SER B 342 72.82 52.08 REMARK 500 GLU B 343 37.51 38.32 REMARK 500 LEU B 393 56.12 -92.41 REMARK 500 SER B 428 110.36 -171.62 REMARK 500 GLN B 430 -17.84 75.60 REMARK 500 GLN B 454 14.01 -64.35 REMARK 500 VAL B 455 -38.92 -134.59 REMARK 500 LYS B 474 -70.07 -27.95 REMARK 500 LYS C 240 49.67 -80.20 REMARK 500 ASP C 243 142.70 -32.59 REMARK 500 SER C 342 72.28 55.10 REMARK 500 GLU C 343 42.31 39.74 REMARK 500 LEU C 393 41.60 -76.26 REMARK 500 GLU C 427 42.28 -100.03 REMARK 500 SER C 428 92.96 -165.72 REMARK 500 ASP C 462 63.84 -107.98 REMARK 500 SER C 464 19.42 -142.94 REMARK 500 LEU C 465 115.12 -14.52 REMARK 500 SER D 342 70.75 51.62 REMARK 500 GLU D 343 38.93 38.91 REMARK 500 SER D 355 4.67 -68.91 REMARK 500 LEU D 393 57.32 -93.59 REMARK 500 SER D 428 111.52 -173.49 REMARK 500 GLN D 430 -17.41 75.06 REMARK 500 GLN D 454 14.23 -65.24 REMARK 500 VAL D 455 -41.36 -133.61 REMARK 500 LYS D 474 -71.50 -29.37 REMARK 500 ASP D 475 41.35 -108.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 239 LYS A 240 -144.30 REMARK 500 PHE A 264 LYS A 265 -146.90 REMARK 500 GLY C 239 LYS C 240 -143.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 731 DISTANCE = 6.78 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA C 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA C 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA D 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AJA D 802 DBREF 2OM9 A 204 477 UNP P37231 PPARG_HUMAN 232 505 DBREF 2OM9 B 204 477 UNP P37231 PPARG_HUMAN 232 505 DBREF 2OM9 C 204 477 UNP P37231 PPARG_HUMAN 232 505 DBREF 2OM9 D 204 477 UNP P37231 PPARG_HUMAN 232 505 SEQADV 2OM9 GLY A 200 UNP P37231 EXPRESSION TAG SEQADV 2OM9 SER A 201 UNP P37231 EXPRESSION TAG SEQADV 2OM9 HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 2OM9 MET A 203 UNP P37231 EXPRESSION TAG SEQADV 2OM9 GLY B 200 UNP P37231 EXPRESSION TAG SEQADV 2OM9 SER B 201 UNP P37231 EXPRESSION TAG SEQADV 2OM9 HIS B 202 UNP P37231 EXPRESSION TAG SEQADV 2OM9 MET B 203 UNP P37231 EXPRESSION TAG SEQADV 2OM9 GLY C 200 UNP P37231 EXPRESSION TAG SEQADV 2OM9 SER C 201 UNP P37231 EXPRESSION TAG SEQADV 2OM9 HIS C 202 UNP P37231 EXPRESSION TAG SEQADV 2OM9 MET C 203 UNP P37231 EXPRESSION TAG SEQADV 2OM9 GLY D 200 UNP P37231 EXPRESSION TAG SEQADV 2OM9 SER D 201 UNP P37231 EXPRESSION TAG SEQADV 2OM9 HIS D 202 UNP P37231 EXPRESSION TAG SEQADV 2OM9 MET D 203 UNP P37231 EXPRESSION TAG SEQRES 1 A 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 A 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 A 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 A 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 A 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 A 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 A 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 A 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 A 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 A 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 A 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 A 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 A 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 A 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 A 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 A 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 A 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 A 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 A 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 A 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 A 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 A 278 TYR LYS ASP LEU TYR SEQRES 1 B 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 B 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 B 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 B 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 B 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 B 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 B 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 B 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 B 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 B 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 B 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 B 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 B 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 B 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 B 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 B 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 B 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 B 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 B 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 B 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 B 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 B 278 TYR LYS ASP LEU TYR SEQRES 1 C 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 C 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 C 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 C 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 C 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 C 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 C 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 C 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 C 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 C 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 C 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 C 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 C 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 C 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 C 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 C 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 C 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 C 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 C 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 C 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 C 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 C 278 TYR LYS ASP LEU TYR SEQRES 1 D 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 D 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 D 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 D 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 D 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 D 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 D 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 D 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 D 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 D 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 D 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 D 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 D 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 D 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 D 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 D 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 D 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 D 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 D 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 D 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 D 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 D 278 TYR LYS ASP LEU TYR HET AJA A 501 29 HET AJA A 602 29 HET AJA B 502 29 HET AJA B 601 29 HET AJA C 701 29 HET AJA C 702 29 HET AJA D 801 29 HET AJA D 802 29 HETNAM AJA (6AR,10AR)-3-(1,1-DIMETHYLHEPTYL)-1-HYDROXY-6,6- HETNAM 2 AJA DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9- HETNAM 3 AJA CARBOXYLIC ACID HETSYN AJA AJULEMIC ACID; CT-3; IP-751; 1',1'-DIMETHYLHEPTYL- HETSYN 2 AJA DELTA8-TETRAHYDROCANNABINOL-11-OIC ACID FORMUL 5 AJA 8(C25 H36 O4) FORMUL 13 HOH *213(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 ILE A 262 1 12 HELIX 4 4 LEU A 270 LYS A 275 5 6 HELIX 5 5 GLU A 276 CYS A 285 1 10 HELIX 6 6 CYS A 285 LYS A 301 1 17 HELIX 7 7 GLY A 305 LEU A 309 5 5 HELIX 8 8 ASP A 310 LEU A 333 1 24 HELIX 9 9 ARG A 350 LEU A 356 1 7 HELIX 10 10 PRO A 359 PHE A 363 5 5 HELIX 11 11 MET A 364 ALA A 376 1 13 HELIX 12 12 ASP A 380 LEU A 393 1 14 HELIX 13 13 ASN A 402 HIS A 425 1 24 HELIX 14 14 GLN A 430 GLU A 460 1 31 HELIX 15 15 HIS A 466 LYS A 474 1 9 HELIX 16 16 GLU B 207 PHE B 226 1 20 HELIX 17 17 THR B 229 THR B 238 1 10 HELIX 18 18 ASP B 251 ILE B 262 1 12 HELIX 19 19 GLU B 276 CYS B 285 1 10 HELIX 20 20 CYS B 285 ILE B 303 1 19 HELIX 21 21 GLY B 305 LEU B 309 5 5 HELIX 22 22 ASP B 310 MET B 334 1 25 HELIX 23 23 ARG B 350 SER B 355 1 6 HELIX 24 24 PRO B 359 PHE B 363 5 5 HELIX 25 25 MET B 364 ALA B 376 1 13 HELIX 26 26 ASP B 380 LEU B 393 1 14 HELIX 27 27 VAL B 403 HIS B 425 1 23 HELIX 28 28 GLN B 430 GLU B 460 1 31 HELIX 29 29 HIS B 466 LYS B 474 1 9 HELIX 30 30 GLU C 207 PHE C 226 1 20 HELIX 31 31 THR C 229 THR C 238 1 10 HELIX 32 32 ASP C 251 ILE C 262 1 12 HELIX 33 33 LEU C 270 LYS C 275 5 6 HELIX 34 34 GLU C 276 CYS C 285 1 10 HELIX 35 35 CYS C 285 SER C 302 1 18 HELIX 36 36 GLY C 305 LEU C 309 5 5 HELIX 37 37 ASP C 310 LEU C 333 1 24 HELIX 38 38 ARG C 350 LEU C 356 1 7 HELIX 39 39 PRO C 359 PHE C 363 5 5 HELIX 40 40 MET C 364 ALA C 376 1 13 HELIX 41 41 ASP C 380 LEU C 393 1 14 HELIX 42 42 ASN C 402 HIS C 425 1 24 HELIX 43 43 GLN C 430 GLU C 460 1 31 HELIX 44 44 HIS C 466 LYS C 474 1 9 HELIX 45 45 GLU D 207 PHE D 226 1 20 HELIX 46 46 THR D 229 THR D 238 1 10 HELIX 47 47 ASP D 251 ILE D 262 1 12 HELIX 48 48 GLU D 276 CYS D 285 1 10 HELIX 49 49 CYS D 285 ILE D 303 1 19 HELIX 50 50 GLY D 305 LEU D 309 5 5 HELIX 51 51 ASP D 310 MET D 334 1 25 HELIX 52 52 ARG D 350 SER D 355 1 6 HELIX 53 53 PRO D 359 PHE D 363 5 5 HELIX 54 54 MET D 364 LEU D 377 1 14 HELIX 55 55 ASP D 380 LEU D 393 1 14 HELIX 56 56 VAL D 403 HIS D 425 1 23 HELIX 57 57 GLN D 430 GLU D 460 1 31 HELIX 58 58 HIS D 466 LYS D 474 1 9 SHEET 1 A 3 PHE A 247 ILE A 249 0 SHEET 2 A 3 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 3 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346 SHEET 1 C 3 PHE C 247 ILE C 249 0 SHEET 2 C 3 GLY C 346 THR C 349 1 O PHE C 347 N ILE C 249 SHEET 3 C 3 GLY C 338 ILE C 341 -1 N VAL C 339 O MET C 348 SHEET 1 D 3 PHE D 247 ILE D 249 0 SHEET 2 D 3 GLY D 346 THR D 349 1 O PHE D 347 N ILE D 249 SHEET 3 D 3 GLY D 338 ILE D 341 -1 N ILE D 341 O GLY D 346 CISPEP 1 LYS A 358 PRO A 359 0 -6.32 CISPEP 2 LYS B 358 PRO B 359 0 -1.12 CISPEP 3 LYS C 358 PRO C 359 0 2.28 CISPEP 4 LYS D 358 PRO D 359 0 -2.35 SITE 1 AC1 9 PHE A 264 LYS A 265 HIS A 266 CYS A 285 SITE 2 AC1 9 ARG A 288 VAL A 339 SER A 342 MET A 348 SITE 3 AC1 9 LEU A 353 SITE 1 AC2 9 LYS A 301 GLN A 314 VAL A 315 LEU A 318 SITE 2 AC2 9 AJA A 602 VAL B 290 GLN B 294 HIS B 466 SITE 3 AC2 9 LEU B 468 SITE 1 AC3 10 HOH B 102 PHE B 264 LYS B 265 CYS B 285 SITE 2 AC3 10 VAL B 339 ILE B 341 SER B 342 MET B 348 SITE 3 AC3 10 LEU B 353 PHE B 360 SITE 1 AC4 10 HOH A 61 HOH A 155 VAL A 290 HIS A 466 SITE 2 AC4 10 PRO A 467 LEU A 468 LYS B 301 LEU B 311 SITE 3 AC4 10 VAL B 315 AJA B 502 SITE 1 AC5 9 PHE C 264 LYS C 265 HIS C 266 GLY C 284 SITE 2 AC5 9 CYS C 285 ARG C 288 SER C 342 PHE C 360 SITE 3 AC5 9 HOH C 724 SITE 1 AC6 10 VAL C 293 THR C 297 LYS C 301 VAL C 315 SITE 2 AC6 10 LEU C 318 HOH C 717 HOH C 733 VAL D 290 SITE 3 AC6 10 HIS D 466 LEU D 468 SITE 1 AC7 12 HIS C 466 PRO C 467 LEU C 468 GLU C 471 SITE 2 AC7 12 HOH C 717 HOH C 731 HOH C 736 THR D 297 SITE 3 AC7 12 LYS D 301 VAL D 315 LEU D 318 ILE D 472 SITE 1 AC8 7 PHE D 264 HIS D 266 CYS D 285 ILE D 341 SITE 2 AC8 7 SER D 342 MET D 348 PHE D 360 CRYST1 62.344 78.139 104.231 100.10 106.41 90.01 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016040 0.000003 0.004805 0.00000 SCALE2 0.000000 0.012798 0.002380 0.00000 SCALE3 0.000000 0.000000 0.010173 0.00000